# Quality of Life in Patients with Treatment-Resistant Depression Treated with Intranasal Esketamine as Add-On Therapy to an SSRI—A Prospective, Comparative Study in Real-World Clinical Practice

Article · Szawarnoga D, Fojcik J, Górski M, Krzystanek M

- Archive id: pmc:PMC13708465
- Published: 2026-10-01
- Venue: Pharmaceuticals (Basel, Switzerland)
- PMCID: PMC13708465
- Citations: 0
- Source URL: https://europepmc.org/article/PMC/PMC13708465
- PDF: https://europepmc.org/articles/PMC13708465/pdf
- Provenance: europepmc

_Abstract not reproduced: its license does not permit redistribution. See the source URL._

Topics: [Novel Psychiatric Therapeutics](https://space-kitty.com/topics/psychiatric-therapeutics)

Cited in dossiers:
- [Novel Psychiatric Therapeutics: State of the Field (October 2026)](https://space-kitty.com/dossiers/psychiatric-therapeutics)

---
Space Kitty Archive · https://space-kitty.com · API: https://space-kitty.com/api/v1 · MCP: https://space-kitty.com/mcp · Premium: $0.20/request via x402 (Base Sepolia (testnet)). Metadata: arXiv (CC0), OpenAlex (CC0), Europe PMC (CC BY/CC0 works), ClinicalTrials.gov.
